Will Buntanetap from Annovis Bio receive FDA approval before 2028?
9
167
150
2028
13%
chance

The drug is in phase 3 trials now for Parkinson's Disease and Alzheimer's Disease.

AKA Posiphen or ANVS401

Study link here: https://clinicaltrials.gov/ct2/show/NCT05357989

Get Ṁ200 play money
Sort by:

Stock +40% over the past month. Does the market know something we/I don't?

bought Ṁ15 of NO

I have only skimmed information on this but the base rate for drugs actually working for Alzheimer's etc is really low. It may be approved anyway (e.g. aducanumab) though.

More related questions